Mayne Pharma | MYX - 流动资产



金融业
股票价格
AUD
资产
AUD 1.14B
现金及等价物
AUD 110.07M
销售成本
AUD 43.74M
流动资产
AUD 460.59M
流动负债
AUD 313.94M
债务
AUD 38.82M
EBIT
AUD -16.2M
EBITDA
AUD 20.9M
员工
450
EPS每股收益
AUD 0.31
股本和储备
AUD 454.19M
销售毛利
AUD 86.13M
债务利息支出
AUD 1.2M
贷款资金
AUD 2.66M
市值
AUD 239.06M
净收入
AUD -103.68M
营业费用
AUD 103.54M
营业利润
AUD -3.3M
普通股股本
AUD 81.25M
税前利润
AUD -14.7M
销售收入
AUD 86.5M
销售和管理费用
AUD 54.8M
股票
AUD 74.63M
贸易债权人
AUD 30.25M
应收帐款人
AUD 193.22M


流动资产 更改 日
Ansell USD 1.11B 5.2M 2025-12
Avita Medical AUD 35.49M 760K 2025-12
Cochlear AUD 1.37B 43.9M 2025-12
CSL USD 11.85B 1000K 2025-12
Healius AUD 1.04B 737.9M 2024-12
Integral Diagnostics AUD 74.82M 9.15M 2024-06
Medical Developments International AUD 33.75M 1.79M 2025-12
Nanosonics AUD 234.13M 8.81M 2025-12
Polynovo AUD 69.23M 7.87M 2025-12
Ramsay Health Care AUD 3.56B 480.3M 2025-12
ResMed USD 4.06B 245.26M 2026-03
Sigma Healthcare AUD 2.91B 2B 2025-12
Sonic Healthcare AUD 2.3B 52.76M 2024-12
Telix Pharmaceuticals AUD 488.02M 157.74M 2026-06